Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

Top 7 search results for "autologous (serm) stem cell transplant" in Treatments. To see all results and access other features, sign up for free.

Did you mean autologous (stem) stem cell transplant?

Autologous (self) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is the most common treatment for people when first diagnosed with multiple myeloma. The purpose of a stem cell transplant in multiple myeloma is to replace… read more

Allogeneic (donor) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is the most common treatment for people when first diagnosed with multiple myeloma. The purpose of a stem cell transplant in multiple myeloma is to replace… read more

Mozobil (Plerixafor)

Overview
Mozobil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma and non-Hodgkin lymphoma. Mozobil is also known by its drug name, plerixafor.

Mozobil is a… read more

Tecvayli (Teclistamab-cqyv)

Overview
Tecvayli is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy. These… read more

Talvey (Talquetamab-Tgvs)

Overview
Talvey is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy. These…

read more

Carvykti (Ciltacabtagene autoleucel)

Overview
Carvykti is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy.… read more

Elrexfio (Elranatamab-Bcmm)

Overview
Elrexfio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma who’ve received at least four prior lines of therapy,… read more